This New Drug Can Lower Your Cholesterol and Prevent Heart Against Diseases

A recent study has revealed that adding a new biological drug to the existing class of drugs that helps lower cholesterol level may further improve the results, in addition to lowering the risk of heart diseases, including stroke and attack.

According to the research conducted by a group of doctors, the patients who were administered the new class of biological drug were twice less likely to suffer from a cardiac disease as compared to those who were given the conventional treatment, which uses statin drugs such as Lipitor or Zocor.

The combined therapy ''basically halves the rate of cardiovascular events," said Dr Sebatine, a physician at the Brigham and Women's Hospital in Boston, reported WebMD.

The leading drug maker, Amgen, provided the financial support for the study.

“The results are really impressive and very encouraging for the new drugs,” said Dr Judith Hochman from the NYU Langone Medical Center, reported CBCnews.

The group, headed by Sebatine, monitored over 4,000 patients who had completed at least one of the 12 Phase II or Phase III clinical trial of the drug. The patients were randomly given either the standard treatment or the new treatment using the new class of drugs. The cholesterol levels at the end of the treatment showed how the new drug works.

The researchers made it clear that the new class of drugs is not meant to replace statins, but as an additional therapy for patients whose cholesterol levels are not getting controlled with the help of conventional treatment.

The study has been published in the New England Journal of Medicine.

To report a problem or to leave a feedback on the article, send an e-mail to emailtoguneet@gmail.com.